A New Jersey federal judge has upheld the U.S. Patent and Trademark Office's refusal to extend the life of a pair of patents on a cancer drug, rejecting a challenge from the patent owner that claimed the loss of exclusivity would cost it more than $1 billion.
A flurry of policy changes made as part of the Trump administration's anti-fraud efforts will require healthcare companies to answer complex questions around whether a violation is civil, criminal or a combination of the two.
A transparency group's plan to publish the billing codes used by hospitals and payers across the country faces a critical test Thursday in Illinois federal court. Law360 takes a closer look at the case.